Baidu
map

2021年9月28日简报:全国新冠疫苗接种剂次超22亿,新加坡单日新增新冠病例创纪录,“与新冠共处”后被迫收紧防疫措施,拜登接种加强针,美国务院发言人新冠检测结果呈阳性

2021-09-28 MedSci整理 MedSci整理

截至北京时间2021年9月28日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23296万例,新增314,779例,达到232,967,11

截至北京时间2021年9月28日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过23296万例,新增314,779例,达到232,967,119例。累计死亡病例476.7万例,达到4,767,376例。新增死亡为4,727例。康复为209,652,893例,重症和危重症病人达到92,314例;全球新冠确诊病例超过100万例的国家达35个,108个国家病例超10万例。昨日报道:2021年9月27日简报:国产鼻喷新冠疫苗接种24小时即起效;中国累计向全球供应新冠疫苗34亿剂

美国新增确诊病例超9.6万例 美国务院发言人新冠检测结果呈阳性

根据Worldometer实时统计数据,截至北京时间9月28日6时30分左右,美国累计确诊新冠肺炎病例43847193例,累计死亡病例707447例。与前一日6时30分数据相比,美国新增确诊病例96273例,新增死亡病例1134例。

美国国务院发言人内德·普赖斯当地时间9月27日发表声明称,他于27日早上出现新冠肺炎的相关症状,并得到了新冠病毒检测呈阳性的结果。普赖斯表示,他将在接下来的10天内进行隔离观察。

巴西新增确诊病例超1.4万例 巴西总统之子一家三口均感染新冠病毒

据巴西卫生部官网最新数据,截至当地时间9月27日,巴西单日新增新冠肺炎确诊病例14423例,累计确诊病例21366395例;单日新增死亡病例210例,累计死亡594653例。

当地时间9月27日,巴西总统博索纳罗之子、国会众议员爱德华多·博索纳罗的妻子赫洛伊莎·博索纳罗在其社交媒体上称,她和11个月大的女儿的新冠病毒检测结果均为阳性。三天前,爱德华多·博索纳罗确诊感染新冠病毒,他曾作为巴西代表团成员于9月19日随同其父赴美参加第76届联合国大会一般性辩论。

印度新增确诊病例超2.6万例 累计确诊逾3367万例

据印度卫生部27日公布的最新数据,印度新冠肺炎确诊病例升至33678786例。在过去24小时内,印度新增确诊病例26041例;新增死亡病例276例,累计死亡病例达447194例。

俄罗斯新增确诊病例超2.2万例 累计确诊逾744万例

据俄罗斯新冠病毒防疫官网27日公布的最新数据,俄罗斯新增新冠肺炎确诊病例22236例,累计确诊7443149例,新增新冠肺炎死亡病例779例,累计死亡204679例。

泰国新增确诊病例超1万例 累计确诊逾157万例

当地时间9月27日,泰国政府新冠肺炎疫情管理中心通报,该国单日新增新冠肺炎确诊病例10288例,全国累计确诊1571926例,新增死亡病例101例,累计死亡16368例,目前尚有120156名患者正在接受治疗。

新加坡单日新增新冠病例创纪录,“与新冠共处”后被迫收紧防疫措施

8月10日,新加坡开始执行新的防疫政策,政府不再追求零确诊,而是打出了“与冠病(新冠)共处,如常生活”的口号。然而在这一政策执行后,从8月中下旬开始,新加坡新冠确诊人数直线上升。9月26日,新加坡新增确诊病例达1939例,为疫情以来最高。新加坡卫生部甚至预计,在27日开始的新一周里,新加坡每日新增确诊病例将超过3200例。

为此,新加坡不得不从27日起收紧防疫政策,目前暂定为期1个月。上海国际问题研究院亚太研究中心副研究员周士新向第一财经记者表示,对于当前的情形,新加坡在制定共存政策时已有所预期,目前正在集中应对。虽然新加坡此轮疫情的重症率不高,但是疫情大规模传播依然构成重大的公共卫生危机。

他还指出,新加坡“与新冠共存”的政策已对东南亚其他国家有所启发,新加坡接下来的抗疫情势如何,也将会影响到地区其他国家的抗疫决策。

国家卫健委:全国新冠疫苗接种剂次超22亿

据国家卫健委信息,截至2021年9月26日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗220020.2万剂次。

国家卫生健康委员会27日通报,9月26日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增新冠肺炎确诊病例35例。其中境外输入病例22例(云南12例、北京3例、天津1例、辽宁1例、上海1例、江苏1例、浙江1例、山东1例、广东1例),含3例由无症状感染者转为确诊病例(天津1例、浙江1例、广东1例);本土病例13例(黑龙江11例,均在哈尔滨市;福建2例,均在厦门市)。无新增死亡病例,无新增疑似病例。

当日新增治愈出院病例36例,解除医学观察的密切接触者958人,重症病例较前一日减少1例。

境外输入现有确诊病例526例(其中重症病例3例),现有疑似病例2例。累计确诊病例8977例,累计治愈出院病例8451例,无死亡病例。

此外,国家卫健委27日通报,全国新冠疫苗接种超22亿剂次。疫情尚未结束,要毫不放松抓好疫情防控工作,不断巩固和扩大疫情防控成果。国庆假期即将来临,专家提示,要继续做好个人防护,坚持戴口罩、勤洗手、少聚集等良好的卫生习惯。

拜登“以身作则”注射第三针辉瑞(PFE.US)新冠疫苗,再次呼吁美国民众尽快接种

拜登在注射前的讲话中再次呼吁美国民众尽快接种疫苗,并表示他将敦促获得更多的疫苗授权,以提高美国的疫苗接种率。现年78岁的拜登符合美国食品药品管理局(FDA)和疾病预防控制中心(CDC)上周发布的指导方针,即65岁以上群体可以接种第三针疫苗。

拜登指出,全面接种疫苗的美国民众已经得到了高度保护,不会出现严重的疾病。他表示:“绝大多数美国民众正在做正确的事情,超过77%的成年人至少已经打了一针,大约23%的人没有注射任何疫苗,而这一明显的少数群体正在给我们中的许多人造成巨大的损失。”

FDA本月否决了为16岁及以上人群接种辉瑞新冠疫苗加强针的计划,不过该机构同意为65岁以上人群和具有严重疾病的高危人群接种加强针。据悉,加强针将在第二针接种完成至少6个月后注射。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032385, encodeId=62f320323854f, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Tue Jun 21 11:27:58 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083717, encodeId=3d042083e1792, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Oct 16 10:27:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258097, encodeId=48cc125809e39, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402612, encodeId=88bd140261264, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055654, encodeId=acba1055654bb, content=大中国就是好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:48:42 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055568, encodeId=fcaf1055568ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Tue Sep 28 08:10:36 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032385, encodeId=62f320323854f, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Tue Jun 21 11:27:58 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083717, encodeId=3d042083e1792, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Oct 16 10:27:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258097, encodeId=48cc125809e39, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402612, encodeId=88bd140261264, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055654, encodeId=acba1055654bb, content=大中国就是好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:48:42 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055568, encodeId=fcaf1055568ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Tue Sep 28 08:10:36 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032385, encodeId=62f320323854f, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Tue Jun 21 11:27:58 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083717, encodeId=3d042083e1792, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Oct 16 10:27:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258097, encodeId=48cc125809e39, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402612, encodeId=88bd140261264, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055654, encodeId=acba1055654bb, content=大中国就是好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:48:42 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055568, encodeId=fcaf1055568ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Tue Sep 28 08:10:36 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2032385, encodeId=62f320323854f, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Tue Jun 21 11:27:58 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083717, encodeId=3d042083e1792, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Oct 16 10:27:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258097, encodeId=48cc125809e39, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402612, encodeId=88bd140261264, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055654, encodeId=acba1055654bb, content=大中国就是好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:48:42 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055568, encodeId=fcaf1055568ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Tue Sep 28 08:10:36 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2032385, encodeId=62f320323854f, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Tue Jun 21 11:27:58 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083717, encodeId=3d042083e1792, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Oct 16 10:27:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258097, encodeId=48cc125809e39, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402612, encodeId=88bd140261264, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055654, encodeId=acba1055654bb, content=大中国就是好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:48:42 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055568, encodeId=fcaf1055568ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Tue Sep 28 08:10:36 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 13f0c37dm61暂无昵称

    大中国就是好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2032385, encodeId=62f320323854f, content=<a href='/topic/show?id=dfa39e45485' target=_blank style='color:#2F92EE;'>#防疫措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97454, encryptionId=dfa39e45485, topicName=防疫措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Tue Jun 21 11:27:58 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083717, encodeId=3d042083e1792, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Oct 16 10:27:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258097, encodeId=48cc125809e39, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402612, encodeId=88bd140261264, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Sep 29 22:27:58 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055654, encodeId=acba1055654bb, content=大中国就是好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:48:42 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055568, encodeId=fcaf1055568ea, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Tue Sep 28 08:10:36 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 zerohahaha

    好文章

    0

相关资讯

强生表示, 新冠加强注射针有效率高达94%!

美国的病例数仍然处于高度危险中。

2021年9月27日简报:国产鼻喷新冠疫苗接种24小时即起效;中国累计向全球供应新冠疫苗34亿剂

截至北京时间2021年9月27日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23257万例,新增321,182例,达到232,575,14

2021年9月23日简报:哈尔滨新增新冠肺炎本土确诊病例5例;全球已接种新冠疫苗逾60亿剂,中国占近40%达21.8亿剂;哈萨克斯坦出现新冠病毒变异毒株Eta;

截至北京时间2021年9月23日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23080万例,新增492,510例,达到230,805,58

Science:低剂量的Moderna新冠疫苗可引发持久的免疫反应

这个疫苗剂量是是美国食品药品管理局(FDA)紧急授权的100微克Moderna新冠疫苗剂量的四分之一。

2021年9月24日简报:国内针对重点人群开始接种加强针;西安至上海高铁一乘客复核阴性;孕妇接种新冠疫苗可将抗体传给新生儿;

截至北京时间2021年9月24日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23133万例,新增494,371例,达到231,337,47

三叶草重组蛋白新冠疫苗对德尔塔变异株的保护效力为79%(SPECTRA研究)

9月22日,三叶草生物制药有限公司(以下简称“三叶草生物”)和流行病防范创新联盟(CEPI)共同宣布,三叶草生物联合佐剂使用的重组蛋白新冠候选疫苗SCB-2019(CpG 10

Baidu
map
Baidu
map
Baidu
map